Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.11.4377

Advances in the Early Detection of Lung Cancer using Analysis of Volatile Organic Compounds: From Imaging to Sensors  

Li, Wang (Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University)
Liu, Hong-Ying (Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University)
Jia, Zi-Ru (Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University)
Qiao, Pan-Pan (Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University)
Pi, Xi-Tian (Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University)
Chen, Jun (Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University)
Deng, Lin-Hong (Key Laboratory of Biorheology Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.11, 2014 , pp. 4377-4384 More about this Journal
Abstract
According to the World Health Organization (WHO), 1.37 million people died of lung cancer all around the world in 2008, occupying the first place in all cancer-related deaths. However, this number might be decreased if patients were detected earlier and treated appropriately. Unfortunately, traditional imaging techniques are not sufficiently satisfactory for early detection of lung cancer because of limitations. As one alternative, breath volatile organic compounds (VOCs) may reflect the biochemical status of the body and provide clues to some diseases including lung cancer at early stage. Early detection of lung cancer based on breath analysis is becoming more and more valued because it is non-invasive, sensitive, inexpensive and simple. In this review article, we analyze the limitations of traditional imaging techniques in the early detection of lung cancer, illustrate possible mechanisms of the production of VOCs in cancerous cells, present evidence that supports the detection of such disease using breath analysis, and summarize the advances in the study of E-noses based on gas sensitive sensors. In conclusion, the analysis of breath VOCs is a better choice for the early detection of lung cancer compared to imaging techniques. We recommend a more comprehensive technique that integrates the analysis of VOCs and non-VOCs in breath. In addition, VOCs in urine may also be a trend in research on the early detection of lung cancer.
Keywords
Lung cancer; volatile organic compounds; early detection; electronic nose; sensor;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 McCulloch M, Jezierski T, Broffman M, et al (2006). Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther, 5, 30-9.   DOI
2 McWilliams A, Mayo J, MacDonald S, et al (2003). Lung Cancer Screening A Different Paradigm. Am J Respir Crit Care Med, 168, 1167-73.   DOI
3 Melamed MR, Flehinger BJ, Zaman MB, et al (1984). Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest, 86, 44-53.
4 Miyazu YM, Miyazawa T, Hiyama K, et al (2005). Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res, 65, 9623-7.   DOI   ScienceOn
5 Moser E, McCulloch M (2010). Canine scent detection of human cancers: A review of methods and accuracy. J Vet Behav, 5, 145-52.   DOI
6 Peng G, Hakim M, Broza YY, et al (2010). Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer, 103, 542-51.   DOI
7 Oken MM, Hocking WG, Kvale PA, et al (2011). Screening by Chest Radiograph and Lung Cancer Mortality The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial. JAMA, 306, 1865-73.   DOI
8 Pauling L, Robinson AB, Teranishi R, Cary P (1971). Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA, 68, 2374-6.   DOI
9 Peled N, Barash O, Tisch U, et al (2013). Volatile fingerprints of cancer specific genetic mutations. Nanomed Nanotechnol, 9, 758-66.   DOI
10 Peng G, Tisch U, Adams O, et al (2009). Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol, 4, 669-73.   DOI   ScienceOn
11 Phillips M, Altorki N, Austin JHM (2007). Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark, 3, 95-109.
12 Phillips M, Cataneo RN, Cummin AR, et al (2003). Detection of lung cancer with volatile markers in the breath. Chest, 123, 2115-23.   DOI   ScienceOn
13 Phillips M, Gleeson K, Hughes JM, et al (1999). Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet, 353, 1930-3.   DOI
14 Phillips M, Herrera J, Krishnan S, et al (1999). Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl, 729, 75-88.   DOI   ScienceOn
15 Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004). Oxidative stress and cell signalling. Curr Med Chem, 11, 1163-82.   DOI   ScienceOn
16 Roos PH, Tschirbs S, Pfeifer F, et al (2004). Risk potentials for humans of original and remediated PAH-contaminated soils: application of biomarkers of effect. Toxicology, 205, 181-94.   DOI
17 Pysanenko A, Span.l P, Smith D (2008). A study of sulfur-containing compounds in mouth- and nose-exhaled breath and in the oral cavity using selected ion flow tube mass spectrometry. J Breath Res, 2, 046004.   DOI
18 Rami Porta R (1999). Surgical exploration of the mediastinum by mediastinoscopy, parasternal mediastinotomy and remediastinoscopy: indications, technique and complications. Ann Ital Chir, 70, 867-72.
19 Ramshankar V, Krishnamurthy A (2013). Lung cancer detection by screening - presenting circulating miRNAs as a promising next generation biomarker breakthrough. Asian Pac J Cancer Prev, 14, 2167-72.   과학기술학회마을   DOI   ScienceOn
20 Santonico M, Lucantoni G, Pennazza G, et al (2012). In situ detection Of lung cancer volatile fingerprints using bronchoscopic air-sampling. Lung Cancer, 77, 46-50.   DOI
21 Sauerbrey G (1959). Use of vibrating quartz for thin film weighing and microweighing. Z Phys, 155, 206-22.   DOI
22 Semelka RC, Armao DM, Elias J Jr, Huda W (2007). Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging, 25, 900-9.   DOI   ScienceOn
23 Smith D, Wang T, Sule-Suso J, et al (2003). Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom, 17, 845-50.   DOI
24 Sozzi G, Conte D, Leon M, et al (2003). Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol, 21, 3902-8.   DOI   ScienceOn
25 Spiro SG, Navani N (2012). Screening for lung cancer: Is this the way forward? Respirology, 17, 237-46.   DOI
26 Tockman MS, Mulshine JL (1997). Sputum screening by quantitative microscopy: a new dawn for detection of lung cancer? Mayo Clin Proc, 72, 788-90.   DOI
27 Tanner NT, Mehta H, Silvestri GA (2012). New testing for lung cancer screening. Oncology, 26, 176-82.
28 Tisch U, Billan S, Ilouze M (2012). Volatile organic compounds in exhaled breath as biomarkers for the early detection and screening of lung cancer. CML Lung Cancer, 5, 107-17.
29 Valko M, Rhodes CJ, Moncol J, et al (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160, 1-40.   DOI   ScienceOn
30 Wang D, Yu K, Wang Y (2012). A hybrid electronic noses'system based on mos-saw detection units intended for lung cancer diagnosis. J Innov Opt Health Sci, 5, 1150006.   DOI
31 Wang Y, Gu J, Roth JA, et al (2013). Pathway-based serum microRNA profiling and survival in patients with advanced non-small cell lung cancer. Cancer Res, 73, 4801-9.   DOI
32 Williams H, Pembroke A (1989). Sniffer dogs in the melanoma clinic? Lancet, 1, 734.
33 Wilson A D, Baietto M (2009). Applications and advances in electronic-nose technologies. Sensors (Basel), 9, 5099-148.   DOI   ScienceOn
34 Wohltjen H (1984). Mechanism of operation and design considerations for surface acoustic-wave device vapor sensors. Sens Actuators, 5, 307-25.   DOI
35 Xiang D, Zhang B, Doll D, et al (2013). Lung cancer screening: from imaging to biomarker. Biomarker Res, 1, 1-10.   DOI
36 Yang SY, Xiao XY, Zhang WG, et al (2005). Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer, 5, 83.   DOI
37 Yao Q, Sun JG, Ma H, et al (2014). Monitoring microRNAs using a molecular beacon in CD133+/ CD338+ human lung adenocarcinoma-initiating A549 cells. Asian Pac J Cancer Prev, 15, 161-6.   과학기술학회마을   DOI   ScienceOn
38 Yu H, Xu L, Cao MF (2003). Detection volatile organic compounds in breath as markers of lung cancer using a novel electronic nose. Proceedings of the IEEE Sensors, 2, 1333-7.
39 Zhong D, Guo L, de Aguirre I, et al (2006). LKB1 mutation in large cell carcinoma of the lung. Lung Cancer, 53, 285-94.   DOI
40 Barash O, Peled N, Hirsch FR, Haick H (2009). Sniffing the unique “odor print” of non small cell lung cancer with gold nanoparticles. Small, 5, 2618-24.   DOI
41 Albert KJ, Lewis NS, Schauer CL, et al (2000). Cross-reactive chemical sensor arrays. Chem Rev, 100, 2595-626.   DOI   ScienceOn
42 Aberle DR, Adams AM, Berg CD, et al (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 365, 395-409.   DOI   ScienceOn
43 Aksenov AA, Gojova A, Zhao W, et al (2012). Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's “chemical odor fingerprint”. Chembiochem, 13, 1053-9.   DOI
44 Barash O, Peled N, Tisch U, et al (2012). Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine, 8, 580-9.   DOI
45 Belinsky SA, Klinge DM, Dekker JD, et al (2005). Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res, 11, 6505-11.   DOI   ScienceOn
46 Boedeker E, Friedel G, Walles T (2012). Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening. Interact Cardiovasc Thorac Surg, 14, 511-5.   DOI
47 Brosseau C, Boulic F, Queffelec P (1997). Dielectric and microstructure properties of polymer carbon black composites. J Appl Phys, 81, 882-91.   DOI
48 Castro M, Kumar B, Feller JF (2011). Novel e-nose for the discrimination of volatile organic biomarkers with an array of carbon nanotubes (CNT) conductive polymer nanocomposites (CPC) sensors. Sens Actuators B: Chemical, 159, 213-9.   DOI
49 Chen X, Cao MF, Li Y (2005). A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method. Meas Sci Technol, 16, 1535-46.   DOI
50 Chow KK, Short M, Zeng H (2012). A comparison of spectroscopic techniques for human breath analysis. Biomedical Spectroscopy Imaging, 1, 339-53.
51 Chung-man Ho J, Zheng S, Comhair SA, et al (2001). Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res, 61, 8578-85.
52 D'Amico A, Pennazza G, Santonico M, et al (2010). An investigation on electronic nose diagnosis of lung cancer. Lung Cancer, 68, 170-6.   DOI
53 Doria-Rose VP, Marcus PM (2009). Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: An example from the Mayo Lung Project. Lung Cancer, 63, 295-300.   DOI
54 De Wever W, Ceyssens S, Mortelmans L, et al (2007). Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol, 17, 23-32.   DOI   ScienceOn
55 Detterbeck FC, DeCamp MM Jr, Kohman LJ, Silvestri GA (2003). Lung cancer. Invasive staging: the guidelines. Chest, 123, 167-75.   DOI
56 Di Natale C, Macagnano A, Martinelli E, et al (2003). Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron, 18, 1209-18.   DOI   ScienceOn
57 Doria-Rose VP, Marcus PM, Szabo E, et al (2009). Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer, 115, 5007-17.   DOI   ScienceOn
58 Ehmann R, Boedeker E, Friedrich U, et al (2012). Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J, 39, 669-76.   DOI
59 Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. 2010 [Internet]: Lyon, France: International Agency for Research on Cancer.
60 Field JK, Smith RA, Aberle DR, et al (2012). International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol, 7, 10-9.   DOI
61 Flehinger BJ, Melamed MR, Zaman MB, et al (1984). Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis, 130, 555-60.
62 Frost JK, Ball WC Jr, Levin ML, et al (1984). Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis, 130, 549-54.
63 Fontana RS, Sanderson DR, Taylor WF, et al (1984). Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis, 130, 561-5.
64 Fossella F, Komaki R, Putnam J (2003). Lung Cancer. MD Anderson Cancer Care Series. New York, NY Springer-Verlag.
65 Ghosal R, Kloer P, Lewis KE (2009). A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad Med J, 85, 358-63.   DOI
66 Gordon SM, Szidon JP, Krotoszynski BK, et al (1985). Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem, 31, 1278-82.
67 Hakim M, Broza YY, Barash O, et al (2012). Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev, 112, 5949-66.   DOI
68 Halliwell B (1996). Antioxidants in human health and disease. Annu Rev Nutr, 16, 33-50.   DOI   ScienceOn
69 Hanai Y, Shimono K, Matsumura K, et al (2012). Urinary volatile compounds as biomarkers for lung cancer. Biosci Biotechnol Biochem, 76, 679-84.   DOI
70 Hardie DG, Hawley SA, Scott JW (2006). AMP-activated protein kinase--development of the energy sensor concept. J Physiol, 574, 7-15.   DOI   ScienceOn
71 Hochhegger B, Marchiori EIrion K (2013). MRI in lymph node staging of lung cancer. AJR Am J Roentgenol, 200, 540.   DOI
72 Hujala KT, Sipila JI, Grenman R (2001). Mediastinoscopy--its role and value today in the differential diagnosis of mediastinal pathology. Acta Oncol, 40, 79-82.   DOI
73 Holty JE, Kuschner WG, Gould MK (2005). Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax, 60, 949-55.   DOI
74 Hou C, Dong J, Zhang G, et al (2011). Colorimetric artificial tongue for protein identification. Biosens Bioelectron, 26, 3981-6.   DOI
75 Hou C, Lei J, Huo D (2013). Discrimination of Lung Cancer Related Volatile Organic Compounds with a Colorimetric Sensor Array. Anal Lett, 46, 2048-59.   DOI
76 Janzen MC, Ponder JB, Bailey DP, et al (2006). Colorimetric sensor arrays for volatile organic compounds. Anal Chem, 78, 3591-600.   DOI   ScienceOn
77 Karki S, Yin Yj, Samanai N et al (2013). Breathe analyzer and its importance for the early detection of lung cancer. Sky J Med Med Sci, 1, 7-9.
78 Kneepkens CM, Lepage G, Roy CC (1994). The potential of the hydrocarbon breath test as a measure of lipid-peroxidation. Free Radic Biol Med, 17, 127-60.   DOI
79 Kubik A, Polak J (1986). Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer, 57, 2427-37.   DOI
80 Leng S, Do K, Yingling CM, et al (2012). Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res, 18, 3387-95.   DOI
81 Marnett LJ (2000). Oxyradicals and DNA damage. Carcinogenesis, 21, 361-70.   DOI   ScienceOn
82 Mazzone PJ, Wang XF, Xu Y, et al (2012). Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol, 7, 137-42.   DOI
83 Mazzone PJ (2008). Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol, 3, 774-80.   DOI   ScienceOn
84 Mazzone PJ, Hammel J, Dweik R, et al (2007). Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax, 62, 565-8.   DOI
85 Mazzone PJ, Obuchowski N, Phillips M, et al (2013). Lung cancer screening with computer aided detection chest radiography: design and results of a randomized, controlled trial. PLOS ONE, 8, 59650.   DOI
86 Brett GZ (1968). The value of lung cancer detection by six-monthly chest radiographs. Thorax, 23, 414-20.   DOI   ScienceOn
87 Fontana RS, Sanderson DR, Woolner LB, et al (1986). Lung-Cancer Screening - the Mayo Program. J Occup Med, 28, 746-50.   DOI
88 Tanaka K, Akechi T, Okuyama T, et al (2002). Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage, 23, 484-9.   DOI   ScienceOn
89 Marcus PM, Bergstralh EJ, Fagerstrom RM, et al (2000). Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst, 92, 1308-16.   DOI   ScienceOn
90 Muro ML, Daws CA, Castellano FN (2008). Microarray pattern recognition based on Pt(II) terpyridyl chloride complexes: vapochromic and vapoluminescent response. Chem Commun, 14, 6134-6.
91 Poyton RO, Ball KA, Castello PR (2009). Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab, 20, 332-40.   DOI   ScienceOn